HT
KYNB

HAP Trading’s Kyntra Bio KYNB Stock Holding History

HAP Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-787
Closed -$201K – 2634
2021
Q3 		$201K Buy
787
+349
+80% +$124K 0.01% 1037
2021
Q2 		$292K Buy
+438
New +$252K 0.01% 844
2019
Q4 		– Sell
-706
Closed -$721K – 1308
2019
Q3 		$652K Buy
+706
New +$775K 0.05% 269
2018
Q4 		– Sell
-2,321
Closed -$3.52M – 1173
2018
Q3 		$3.52M Sell
2,321
-227
-9% -$350K 0.22% 97
2018
Q2 		$3.99M Buy
+2,548
New +$3.32M 0.2% 90

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HAP Trading's KYNB Position: Q4 2021 in Review

HAP Trading sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 787 shares — an estimated $201K sold.

HAP Trading first reported a position in KYNB in Q2 2018 and held it in 5 quarters. The position peaked at $3.99M in Q2 2018. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • HAP Trading reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 787 Kyntra Bio shares in Q4 2021, an estimated $201K.
  • HAP Trading first reported a position in Kyntra Bio in Q2 2018 and held it in 5 quarters.
  • HAP Trading's Kyntra Bio position peaked at $3.99M in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.